Elutia (ELUT) Non Operating Income (2025 - 2026)

Elutia (ELUT) reported Non Operating Income of $108000.0 for Q1 2026, up 158.7% on a YoY basis from $41747.9 in Q1 2025, and up 158.7% sequentially from -$184000.0 in Q1 2025.

Elutia (ELUT) Non Operating Income (2025 - 2026) Analysis & Trends

Elutia (ELUT) has 2 years of Non Operating Income data on file, last reported at $108000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 62.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -18.60 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Elutia 39.99 Mn 11.50 Mn 1.80 Mn 108,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 108,000.00
Mar 31, 2025 -184,000.00